Patents by Inventor Kevin Gregory Hoff

Kevin Gregory Hoff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11972840
    Abstract: Provided herein are systems and methods for screening desirable biological variants using a high-throughput integrated system. The integrated system may be configured to input a plurality of parameters from functional studies of biological variants under applied conditions, in conjunction with integrated libraries of biological variants, and filter the inputs to produce desirable biological variants based on an input performance requirement. The system may output optimized strains, molecules, or novel molecules expected to have a desirable functional characteristic. Accordingly, the methods and systems disclosed herein enable multi-parametric studies of biological diversity and conditional diversity in systems biology.
    Type: Grant
    Filed: December 20, 2022
    Date of Patent: April 30, 2024
    Assignee: TRIPLEBAR BIO, INC.
    Inventors: Jeremy Agresti, Andres Ornelas Vargas, Kevin Gregory Hoff
  • Patent number: 11923045
    Abstract: Provided herein are systems and methods for screening desirable biological variants using a high-throughput integrated system. The integrated system may be configured to input a plurality of parameters from functional studies of biological variants under applied conditions, in conjunction with integrated libraries of biological variants, and filter the inputs to produce desirable biological variants based on an input performance requirement. The system may output optimized strains, molecules, or novel molecules expected to have a desirable functional characteristic. Accordingly, the methods and systems disclosed herein enable multi-parametric studies of biological diversity and conditional diversity in systems biology.
    Type: Grant
    Filed: December 20, 2022
    Date of Patent: March 5, 2024
    Assignee: TRIPLEBAR BIO, INC.
    Inventors: Jeremy Agresti, Andres Ornelas Vargas, Kevin Gregory Hoff
  • Publication number: 20230174968
    Abstract: Provided herein are systems and methods for screening desirable biological variants using a high-throughput integrated system. The integrated system may be configured to input a plurality of parameters from functional studies of biological variants under applied conditions, in conjunction with integrated libraries of biological variants, and filter the inputs to produce desirable biological variants based on an input performance requirement. The system may output optimized strains, molecules, or novel molecules expected to have a desirable functional characteristic. Accordingly, the methods and systems disclosed herein enable multi-parametric studies of biological diversity and conditional diversity in systems biology.
    Type: Application
    Filed: December 20, 2022
    Publication date: June 8, 2023
    Inventors: Jeremy AGRESTI, Andres ORNELAS VARGAS, Kevin Gregory HOFF
  • Publication number: 20230154562
    Abstract: Provided herein are systems and methods for screening desirable biological variants using a high-throughput integrated system. The integrated system may be configured to input a plurality of parameters from functional studies of biological variants under applied conditions, in conjunction with integrated libraries of biological variants, and filter the inputs to produce desirable biological variants based on an input performance requirement. The system may output optimized strains, molecules, or novel molecules expected to have a desirable functional characteristic. Accordingly, the methods and systems disclosed herein enable multi-parametric studies of biological diversity and conditional diversity in systems biology.
    Type: Application
    Filed: December 20, 2022
    Publication date: May 18, 2023
    Inventors: Jeremy AGRESTI, Andres ORNELAS VARGAS, Kevin Gregory HOFF
  • Publication number: 20210277426
    Abstract: Disclosed are methods and engineered microorganisms that enhance or improve the production of crotyl alcohol. The engineered microorganisms include genetic modifications in alcohol dehydrogenase, alkene reductase or both enzymatic activities. By such genetic modifications, a crotyl alcohol production pathway is provided or improved.
    Type: Application
    Filed: November 19, 2020
    Publication date: September 9, 2021
    Inventors: Stephanie J. Culler, Nicholas Eakley, Kevin Gregory Hoff, Robin E. Osterhout, Priti Pharkya, Erik C. Ralph, Stephen J. Van Dien
  • Patent number: 10844404
    Abstract: Disclosed are methods and engineered microorganisms that enhance or improve the production of crotyl alcohol. The engineered microorganisms include genetic modifications in alcohol dehydrogenase, alkene reductase or both enzymatic activities. By such genetic modifications, a crotyl alcohol production pathway is provided or improved.
    Type: Grant
    Filed: April 7, 2016
    Date of Patent: November 24, 2020
    Assignee: Genomatica Inc.
    Inventors: Stephanie J. Culler, Nicholas Eakley, Kevin Gregory Hoff, Robin E. Osterhout, Priti Pharkya, Erik C. Ralph, Stephen Van Dien
  • Publication number: 20180135082
    Abstract: Disclosed are methods and engineered microorganisms that enhance or improve the production of crotyl alcohol. The engineered microorganisms include genetic modifications in alcohol dehydrogenase, alkene reductase or both enzymatic activities. By such genetic modifications, a crotyl alcohol production pathway is provided or improved.
    Type: Application
    Filed: April 7, 2016
    Publication date: May 17, 2018
    Applicant: GENOMATICA, iNC.
    Inventors: Stephanie J. Culler, Nicholas Eakley, Kevin Gregory Hoff, Robin E. Osterhout, Priti Pharkya, Erik C. Ralph, Stephen Van Dien